CDT Equity 1 article

CDT Equity is an asset-development company that carries pharmaceutical-development capabilities from the former Conduit Pharmaceuticals platform while also incorporating a digital-asset treasury strategy. Its life-science work includes repositioning licensed therapeutic assets, solid-form and co-crystal chemistry, indication discovery and out-licensing. The mixed operating model distinguishes CDT Equity from a conventional clinical-stage biotech and requires both pharmaceutical-asset and treasury context for accurate entity matching.